DC

Devesh Chandrakant Shah

Active Director Director DIN 09557470
DIN 09557470 First appointment Mar 2022 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Mar 2022
Shareholding value •••• Premium profile

About Devesh Chandrakant Shah

Data last updated:

Devesh Chandrakant Shah is a Director at Bayer Science And Innovation Private Limited (since 2023), Director at Bayer Investments India Private Limited (since 2025) and Director at Bayer Foundation India (since 2023), and holds 1 more current directorship. The companies operate in Agriculture, Financial Services and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹1,759 Cr; the largest is Bayer Science And Innovation Private Limited at ₹947 Cr (FY 2025). Earlier, Devesh Chandrakant Shah was a Director at 2022 Es Discovery India Private Limited (2022).

DIN 09557470
Primary Designation Director
Industry Agriculture
First Appointment 31 Mar 2022
Oldest Company Age 30 yrs
Largest company Bayer Science And Innovation Private Limited · ₹947 Cr (FY 2025)
Combined revenue ₹1,759 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Nov 20231996₹947 Cr (FY 2025)Active
Director26 Mar 20252014₹812 Cr (FY 2019)Active
Bayer Foundation India U85191MH2011NPL220674
Director13 Jul 20232011₹48.8 Lakh (FY 2025)Active
Director03 Dec 20252025Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20222022₹115 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
The Good Rice Alliance Private Limited
Bayer Investments India Private Limited
Bayer Science And Innovation Private Limited
Bayer Foundation India
Premium access

Shareholding and investment profile for Devesh Chandrakant Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devesh Chandrakant Shah

Devesh Chandrakant Shah currently holds 4 directorships: Bayer Science And Innovation Private Limited (Director, since 06 Nov 2023, revenue ₹947 Cr (FY 2025)); Bayer Investments India Private Limited (Director, since 26 Mar 2025, revenue ₹812 Cr (FY 2019)); Bayer Foundation India (Director, since 13 Jul 2023, revenue ₹48.8 Lakh (FY 2025)); The Good Rice Alliance Private Limited (Director, since 03 Dec 2025).

Devesh Chandrakant Shah was first appointed on 31 Mar 2022 as Director at 2022 Es Discovery India Private Limited. The most recent appointment on record is 03 Dec 2025 at The Good Rice Alliance Private Limited.

The 3 current companies of Devesh Chandrakant Shah that report revenue have a combined latest revenue of ₹1,759 Cr: Bayer Science And Innovation Private Limited ₹947 Cr (FY 2025); Bayer Investments India Private Limited ₹812 Cr (FY 2019); Bayer Foundation India ₹48.8 Lakh (FY 2025).

Devesh Chandrakant Shah held 1 earlier board appointment: 2022 Es Discovery India Private Limited (Director, 31 Mar 2022 to 30 Sep 2022).

The current boards of Devesh Chandrakant Shah's companies include Kolappan Esaki Muthu (Bayer Science And Innovation Private Limited), Sharda Rohit Gupta (Bayer Science And Innovation Private Limited), Tanvi Hiten Vasa (Bayer Science And Innovation Private Limited), Sunil Prakashlal Narwani (Bayer Investments India Private Limited), Ashish Shashikant Gawde (Bayer Foundation India), Rachana Panda (Bayer Foundation India), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available